Literature DB >> 27864419

How Subclonal Modeling Is Changing the Metastatic Paradigm.

Geoff Macintyre1, Peter Van Loo2,3, Niall M Corcoran4,5, David C Wedge6, Florian Markowetz7, Christopher M Hovens8,5.   

Abstract

A concerted effort to sequence matched primary and metastatic tumors is vastly improving our ability to understand metastasis in humans. Compelling evidence has emerged that supports the existence of diverse and surprising metastatic patterns. Enhancing these efforts is a new class of algorithms that facilitate high-resolution subclonal modeling of metastatic spread. Here we summarize how subclonal models of metastasis are influencing the metastatic paradigm. Clin Cancer Res; 23(3); 630-5. ©2016 AACR. ©2016 American Association for Cancer Research.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 27864419     DOI: 10.1158/1078-0432.CCR-16-0234

Source DB:  PubMed          Journal:  Clin Cancer Res        ISSN: 1078-0432            Impact factor:   12.531


  17 in total

1.  Harnessing Human Microphysiology Systems as Key Experimental Models for Quantitative Systems Pharmacology.

Authors:  D Lansing Taylor; Albert Gough; Mark E Schurdak; Lawrence Vernetti; Chakra S Chennubhotla; Daniel Lefever; Fen Pei; James R Faeder; Timothy R Lezon; Andrew M Stern; Ivet Bahar
Journal:  Handb Exp Pharmacol       Date:  2019

Review 2.  Genomic and phenotypic heterogeneity in prostate cancer.

Authors:  Michael C Haffner; Wilbert Zwart; Martine P Roudier; Lawrence D True; William G Nelson; Jonathan I Epstein; Angelo M De Marzo; Peter S Nelson; Srinivasan Yegnasubramanian
Journal:  Nat Rev Urol       Date:  2020-12-16       Impact factor: 14.432

3.  Multi-regional sequencing reveals clonal and polyclonal seeding from primary tumor to metastases in advanced gastric cancer.

Authors:  Yosuke Hirotsu; Masao Hada; Kenji Amemiya; Toshio Oyama; Hitoshi Mochizuki; Masao Omata
Journal:  J Gastroenterol       Date:  2020-01-07       Impact factor: 7.527

Review 4.  Prostate Cancer Epigenetic Plasticity and Enhancer Heterogeneity: Molecular Causes, Consequences and Clinical Implications.

Authors:  Jeroen Kneppers; Andries M Bergman; Wilbert Zwart
Journal:  Adv Exp Med Biol       Date:  2022       Impact factor: 3.650

5.  Combination of Brachytherapy with Iodine-125 Seeds and Systemic Chemotherapy versus Systemic Chemotherapy Alone for Synchronous Extracranial Oligometastatic Non-Small Cell Lung Cancer.

Authors:  Huzi Li; Zhendong Duan; Cheng Zhao; Wenyan Fang; Yingjie Jia; Xiaojiang Li; Fanming Kong; Lujun Zhao
Journal:  Cancer Manag Res       Date:  2020-09-09       Impact factor: 3.989

6.  Predicting clone genotypes from tumor bulk sequencing of multiple samples.

Authors:  Sayaka Miura; Karen Gomez; Oscar Murillo; Louise A Huuki; Tracy Vu; Tiffany Buturla; Sudhir Kumar
Journal:  Bioinformatics       Date:  2018-12-01       Impact factor: 6.937

7.  Multi-cancer analysis of clonality and the timing of systemic spread in paired primary tumors and metastases.

Authors:  Zheng Hu; Zan Li; Zhicheng Ma; Christina Curtis
Journal:  Nat Genet       Date:  2020-05-18       Impact factor: 38.330

8.  Somatic Trp53 mutations differentially drive breast cancer and evolution of metastases.

Authors:  Yun Zhang; Shunbin Xiong; Bin Liu; Vinod Pant; Francis Celii; Gilda Chau; Ana C Elizondo-Fraire; Peirong Yang; Mingjian James You; Adel K El-Naggar; Nicholas E Navin; Guillermina Lozano
Journal:  Nat Commun       Date:  2018-09-27       Impact factor: 14.919

9.  Inferring parsimonious migration histories for metastatic cancers.

Authors:  Mohammed El-Kebir; Gryte Satas; Benjamin J Raphael
Journal:  Nat Genet       Date:  2018-04-26       Impact factor: 38.330

Review 10.  Oligometastatic non-small cell lung cancer: Current management.

Authors:  Alicia Román-Jobacho; María Hernández-Miguel; María Jesús García-Anaya; Jaime Gómez-Millán; J A Medina-Carmona; Ana Otero-Romero
Journal:  J Clin Transl Res       Date:  2021-05-27
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.